Valuation
- The stock appears fairly valued, with elevated TTM P/E reflecting lower recent earnings and a P/B ratio above book value typical for asset-heavy firms. The current price sits near the midpoint of a reasonable target range.
- Current market price as of 2026-04-17 was $183.99
- Trailing Twelve Months (TTM) P/E is 29.58, which is elevated
- Forward (Dynamic) P/E is 19.52, based on future earnings estimates
- Price-to-Book (P/B) ratio is 1.92, indicating market values the company above its accounting book value
- Price-to-Sales (P/S) ratio is 1.94
- Stock has traded between approximately $166.66 and $214.71 over the provided 60-day period
- Using Forward P/E of 19.52 and annual Diluted EPS of $6.63 yields a value of ~$129, but this doesn't account for expected earnings recovery
- With a P/B of 1.92 and an ROE of 7.26%, the stock is not significantly overvalued on an asset basis, but the low ROE tempers justification for a high P/B
- A fundamental-based target price range of $175 - $195 is reasonable
- The current price of $183.99 sits near the midpoint of this range